BUZZ-Albemarle jumps after UBS upgrades to 'buy'
Albemarle's shares rose 6.60% to $127.03 after UBS upgraded the stock to 'buy' from 'neutral', anticipating a rise in lithium prices due to a supply deficit expected in the second half of 2026. UBS also increased the price target to $185, a 55.3% upside. If the U.S. designates lithium as strategic, Albemarle could benefit. Currently, 9 out of 27 analysts rate the stock as 'buy' or 'strong buy'.
Shares of chemical producer Albemarle (ALB.N) rise 6.60% to $127.03
UBS upgrades shares of ALB to “buy” from “neutral,” expecting lithium prices to rise as the market shifts into a supply deficit starting in the second half of 2026
Brokerage also raised PT to $185 from $107, which is a 55.3% upside from its last close
If U.S. designates lithium as strategic and sets a price floor, ALB could benefit via Kings Mountain resource and a two-tier pricing model, brokerage says
9 of 27 analysts rate the stock “buy” or “strong buy”, 16 “hold”, and 2 “sell” or “strong sell; median PT $110 - data compiled by LSEG
As of Thursday’s close, ALB up 38.4% YTD
